These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 32636330)
1. Effect of herpes zoster vaccine and antiviral treatment on risk of ischemic stroke. Yang Q; George MG; Chang A; Tong X; Merritt R; Hong Y Neurology; 2020 Aug; 95(6):e708-e717. PubMed ID: 32636330 [TBL] [Abstract][Full Text] [Related]
2. Herpes Zoster Vaccine Live and Risk of Stroke Among Medicare Beneficiaries: A Population-Based Cohort Study. Yang Q; Chang A; Tong X; Merritt R Stroke; 2021 May; 52(5):1712-1721. PubMed ID: 33874749 [TBL] [Abstract][Full Text] [Related]
3. Risk of, and risk factors for, vasculopathy associated with acute herpes zoster. Yawn BP; Lindsay AC; Yousefi M; Wang C J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106891. PubMed ID: 36473399 [TBL] [Abstract][Full Text] [Related]
4. Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries. Goud R; Lufkin B; Duffy J; Whitaker B; Wong HL; Liao J; Lo AC; Parulekar S; Agger P; Anderson SA; Wernecke M; MaCurdy TE; Weintraub E; Kelman JA; Forshee RA JAMA Intern Med; 2021 Dec; 181(12):1623-1630. PubMed ID: 34724025 [TBL] [Abstract][Full Text] [Related]
5. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015. Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194 [TBL] [Abstract][Full Text] [Related]
6. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines. de Boer PT; van Lier A; de Melker H; van Wijck AJM; Wilschut JC; van Hoek AJ; Postma MJ BMC Med; 2018 Dec; 16(1):228. PubMed ID: 30518427 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine. Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122 [TBL] [Abstract][Full Text] [Related]
9. Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States. Minassian C; Thomas SL; Smeeth L; Douglas I; Brauer R; Langan SM PLoS Med; 2015 Dec; 12(12):e1001919. PubMed ID: 26671338 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 and Risk of Acute Ischemic Stroke Among Medicare Beneficiaries Aged 65 Years or Older: Self-Controlled Case Series Study. Yang Q; Tong X; George MG; Chang A; Merritt RK Neurology; 2022 Feb; 98(8):e778-e789. PubMed ID: 35115387 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older. Izurieta HS; Wernecke M; Kelman J; Wong S; Forshee R; Pratt D; Lu Y; Sun Q; Jankosky C; Krause P; Worrall C; MaCurdy T; Harpaz R Clin Infect Dis; 2017 Mar; 64(6):785-793. PubMed ID: 28362955 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. Le P; Rothberg MB JAMA Intern Med; 2018 Feb; 178(2):248-258. PubMed ID: 29297049 [TBL] [Abstract][Full Text] [Related]
13. Safety of live attenuated herpes zoster vaccine in adults 70-79 years: A self-controlled case series analysis using primary care data from Australia's MedicineInsight program. Totterdell J; Phillips A; Glover C; Chidwick K; Marsh J; Snelling T; Macartney K Vaccine; 2020 May; 38(23):3968-3979. PubMed ID: 32284271 [TBL] [Abstract][Full Text] [Related]
14. Risk of Stroke after Herpes Zoster - Evidence from a German Self-Controlled Case-Series Study. Schink T; Behr S; Thöne K; Bricout H; Garbe E PLoS One; 2016; 11(11):e0166554. PubMed ID: 27880853 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the potential public health impact of Herpes Zoster vaccination in Germany. Curran D; Van Oorschot D; Varghese L; Oostvogels L; Mrkvan T; Colindres R; von Krempelhuber A; Anastassopoulou A Hum Vaccin Immunother; 2017 Oct; 13(10):2213-2221. PubMed ID: 28708959 [TBL] [Abstract][Full Text] [Related]